Treatment of Diabetes in Older Adults: An Endocrine Society Clinical Practice Guideline

Autor: Derek LeRoith, M. Hassan Murad, Irl B. Hirsch, Boris Draznin, Geert Jan Biessels, Mark E. Molitch, Felipe F. Casanueva, Jeffrey B. Halter, Marie E. McDonnell, Susan S Braithwaite, Alan J Sinclair
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Sarcopenia
Endocrinology
Diabetes and Metabolism
Clinical Biochemistry
Disease
Biochemistry
medical
Endocrinology
Diabetic Neuropathies
Health care
Medicine
Mass Screening
Diabetic Nephropathies
Disease management (health)
Aged
80 and over
education.field_of_study
Disease Management
Clinical Practice Guideline
Continuity of Patient Care
Diabetes and Metabolism
Endocrinologists
Hypertension
medicine.medical_specialty
Population
Hyperlipidemias
Diabetes Complications
Prediabetic State
Internal medicine
Diabetes mellitus
Journal Article
Diabetes Mellitus
Hypoglycemic Agents
Humans
Renal Insufficiency
Chronic
education
Intensive care medicine
Adverse effect
Physician's Role
Life Style
Geriatric Assessment
Mass screening
Aged
Biochemistry
medical
Heart Failure
Diabetic Retinopathy
business.industry
Biochemistry (medical)
Guideline
medicine.disease
Atherosclerosis
Diabetes Mellitus
Type 1
Diabetes Mellitus
Type 2
Accidental Falls
business
Zdroj: J Clin Endocrinol Metab
The Journal of clinical endocrinology and metabolism, 104(5), 1520. The Endocrine Society
ISSN: 0021-972X
Popis: Objective The objective is to formulate clinical practice guidelines for the treatment of diabetes in older adults. Conclusions Diabetes, particularly type 2, is becoming more prevalent in the general population, especially in individuals over the age of 65 years. The underlying pathophysiology of the disease in these patients is exacerbated by the direct effects of aging on metabolic regulation. Similarly, aging effects interact with diabetes to accelerate the progression of many common diabetes complications. Each section in this guideline covers all aspects of the etiology and available evidence, primarily from controlled trials, on therapeutic options and outcomes in this population. The goal is to give guidance to practicing health care providers that will benefit patients with diabetes (both type 1 and type 2), paying particular attention to avoiding unnecessary and/or harmful adverse effects.
Databáze: OpenAIRE
Externí odkaz: